CausalSentinel

Protein Dossier — HAVCR2 (Hepatitis A virus cellular receptor 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Non-cancer illness code self-reported: hyperthyroidism or thyrotoxicosis 0.165 0.0416 7.44e-05 Wald ratio 1 cis NA
Non-cancer illness code self-reported: high cholesterol -0.0397 0.0119 8.22e-04 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypothyroidism or myxoedema 0.0567 0.0177 0.00137 Wald ratio 1 cis NA
LDL cholesterol -0.025 0.00802 0.00181 Inverse variance weighted 2 trans NA
LDL cholesterol -0.025 0.00802 0.00181 Inverse variance weighted 2 cis NA
Internalizing problems -0.15 0.0609 0.0136 Wald ratio 1 trans NA
Total cholesterol -0.0242 0.0109 0.0261 Inverse variance weighted 2 trans NA
Total cholesterol -0.0242 0.0109 0.0261 Inverse variance weighted 2 cis NA
Eye problems or disorders: Glaucoma -0.0817 0.0383 0.0328 Wald ratio 1 cis NA
Diagnoses - main ICD10: K35 Acute appendicitis 0.115 0.0542 0.0346 Wald ratio 1 cis NA
Alcohol intake frequency -0.0128 0.00624 0.0396 Wald ratio 1 cis NA
Hirschsprung’s disease 1.32 0.67 0.0489 Wald ratio 1 cis NA
…and 112 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-5134_52_2 TIMD3 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

44 association rows across 29 traits (37 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Hepatitis A virus cellular receptor 2 levels 2e-517 rs7442742 5 GCST90247869 no MR -> candidate analysis
Circulating HAVCR2 levels 4e-316 rs190211816 4 GCST90860595 no MR -> candidate analysis
HAVCR2 protein levels 1e-297 rs147827860 3 GCST90469432 no MR -> candidate analysis
Serum levels of protein HAVCR2 3e-176 rs919744 2 GCST90088950 no MR -> candidate analysis
Hepatitis A virus cellular receptor 2 levels (HAVCR2.5134.52 1e-145 rs6874178 1 GCST90241395 no MR -> candidate analysis
Hepatitis A virus cellular receptor 2 (analyte X5134.52) lev 4e-145 rs6873659 1 GCST90426271 no MR -> candidate analysis
HAVCR1 protein levels 1e-113 rs113319693 3 GCST90469431 no MR -> candidate analysis
Blood protein levels 7e-104 rs4704737 1 GCST006585 no MR -> candidate analysis
Circulating HAVCR1 levels (id: OID00426_OID21422) 9e-97 rs61159436 1 GCST90859787 no MR -> candidate analysis
HAVCR2/TNFRSF1B protein level ratio 3e-80 rs115961055 1 GCST90315030 no MR -> candidate analysis
Circulating HAVCR1 levels (id: OID01075_OID21422) 2e-74 rs61159436 1 GCST90860291 no MR -> candidate analysis
FOLR2/HAVCR2 protein level ratio 2e-66 rs115961055 1 GCST90314865 no MR -> candidate analysis
…and 17 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 797 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
subcutaneous panniculitis-like T-cell lymphoma 0.752 established (curated) no MR -> candidate analysis
late-onset Alzheimers disease 0.43 common-variant locus no MR -> candidate analysis
dementia 0.385 common-variant locus no MR -> candidate analysis

Of the 3 rows above, 3 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 3 known modulators (Hepatitis A virus cellular receptor 2)
gnomAD constraint pLI=0.013, LOEUF=0.838 — LoF-tolerant
GWAS Catalog 105 unique SNPs / 209 rows
ClinVar 101 records; 1 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance